• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾去神经支配:高血压管理的健康专业人员实用指南。

Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension.

作者信息

Schmieder Roland, Burnier Michel, East Cara, Tsioufis Konstantinos, Delaney Sean

机构信息

University Hospital Erlangen, Department of Nephrology and Hypertension Erlangen, Germany.

University Hospital Lausanne, Switzerland.

出版信息

Interv Cardiol. 2023 Mar 7;18:e06. doi: 10.15420/icr.2022.38. eCollection 2023.

DOI:10.15420/icr.2022.38
PMID:37601735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10433107/
Abstract

Growing evidence demonstrates the suitability of renal denervation in a broad population of patients; however, questions remain over its suitability and practical implementation. Given the rapidity of emerging data, this has been a challenging field for potential adopters to navigate. The purpose of this article is twofold: to provide navigation through emerging clinical data and evolving guidance; and to provide physicians with practical, evidence-based advice for identifying eligible patients and providing appropriate management in the pre- and postintervention settings. Although many of these recommendations are based on existing published guidance documents, we reflect equally on our own experiences of using this technology.

摘要

越来越多的证据表明肾去神经支配术适用于广泛的患者群体;然而,其适用性和实际实施仍存在问题。鉴于新出现的数据速度很快,这对潜在采用者来说是一个具有挑战性的领域。本文的目的有两个:梳理新出现的临床数据和不断演变的指南;为医生提供基于证据的实用建议,以识别 eligible 患者,并在干预前和干预后阶段提供适当的管理。虽然这些建议中的许多是基于现有的已发表指南文件,但我们也同样反思了我们自己使用这项技术的经验。 (注:原文中“eligible”未翻译完整,推测可能是“符合条件的”之类意思,可根据完整准确原文进一步完善)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1f/10433107/eee953bbfe50/icr-18-e06-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1f/10433107/fb80c54bc906/icr-18-e06-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1f/10433107/eee953bbfe50/icr-18-e06-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1f/10433107/fb80c54bc906/icr-18-e06-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1f/10433107/eee953bbfe50/icr-18-e06-g002.jpg

相似文献

1
Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension.肾去神经支配:高血压管理的健康专业人员实用指南。
Interv Cardiol. 2023 Mar 7;18:e06. doi: 10.15420/icr.2022.38. eCollection 2023.
2
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.在使用抗高血压药物的情况下肾动脉去神经术的长期疗效和安全性(SPYRAL HTN-ON MED):一项随机、假手术对照试验。
Lancet. 2022 Apr 9;399(10333):1401-1410. doi: 10.1016/S0140-6736(22)00455-X. Epub 2022 Apr 4.
3
2022 Renal denervation therapy for the treatment of hypertension: a statement from the Thai Hypertension Society.2022 年经导管去肾交感神经术治疗高血压:泰国高血压学会立场声明。
Hypertens Res. 2023 Apr;46(4):898-912. doi: 10.1038/s41440-022-01133-6. Epub 2023 Feb 9.
4
Effect of renal denervation on long-term outcomes in patients with resistant hypertension.肾去神经术对耐药性高血压患者长期结局的影响。
Cardiovasc Diabetol. 2021 Jun 5;20(1):117. doi: 10.1186/s12933-021-01309-3.
5
Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial.优化和分级照护标准化抗高血压治疗联合或不联合肾去神经术治疗耐药性高血压(DENERHTN):一项多中心、开放标签、随机对照试验。
Lancet. 2015 May 16;385(9981):1957-65. doi: 10.1016/S0140-6736(14)61942-5. Epub 2015 Jan 26.
6
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.基于导管的肾动脉去神经术治疗耐药性高血压的长期结果:随机 SYMPLICITY HTN-3 试验的最终随访。
Lancet. 2022 Oct 22;400(10361):1405-1416. doi: 10.1016/S0140-6736(22)01787-1. Epub 2022 Sep 18.
7
Consensus and inconsistency between different consensus documents on renal denervation worldwide: the way forward.全球不同肾去神经共识文件之间的一致性和不一致性:前进的方向。
Chin Med J (Engl). 2022 Dec 20;135(24):2926-2937. doi: 10.1097/CM9.0000000000002109.
8
Efficacy and safety of renal denervation for the management of arterial hypertension: A systematic review and meta-analysis of randomized, sham-controlled, catheter-based trials.经导管随机、假对照试验的系统评价和荟萃分析:去肾神经术治疗动脉高血压的疗效和安全性。
J Clin Hypertens (Greenwich). 2020 Apr;22(4):572-584. doi: 10.1111/jch.13827. Epub 2020 Feb 12.
9
[Renal denervation : Really an alternative to reducing blood pressure?].[肾去神经支配:真的是降低血压的一种替代方法吗?]
Internist (Berl). 2022 Mar;63(3):330-340. doi: 10.1007/s00108-021-01242-3. Epub 2022 Jan 14.
10
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.血管内超声肾去神经术治疗高血压(RADIANCE-HTN SOLO):一项多中心、国际、单盲、随机、假对照试验。
Lancet. 2018 Jun 9;391(10137):2335-2345. doi: 10.1016/S0140-6736(18)31082-1. Epub 2018 May 23.

引用本文的文献

1
Efficacy of ultrasound renal denervation reducing blood pressure: a systematic review and meta-analysis.超声肾去神经术降低血压的疗效:一项系统评价和荟萃分析。
REC Interv Cardiol. 2025 Apr 29;7(3):154-163. doi: 10.24875/RECICE.M25000509. eCollection 2025.
2
Renal Denervation After USA FDA Approval: An Update from an Interventional Cardiologist's Perspective.美国食品药品监督管理局(FDA)批准后的肾去神经支配:介入心脏病专家视角的最新进展
J Clin Med. 2025 May 19;14(10):3554. doi: 10.3390/jcm14103554.
3
The Efficacy of Renal Denervation in Treating Resistant Hypertension: A Systematic Review.

本文引用的文献

1
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).经导管去肾交感神经术治疗成人高血压管理:欧洲心脏病学会(ESC)高血压理事会和欧洲经皮心血管介入学会(EAPCI)的临床共识声明。
EuroIntervention. 2023 Mar 20;18(15):1227-1243. doi: 10.4244/EIJ-D-22-00723.
2
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.基于导管的肾动脉去神经术治疗耐药性高血压的长期结果:随机 SYMPLICITY HTN-3 试验的最终随访。
Lancet. 2022 Oct 22;400(10361):1405-1416. doi: 10.1016/S0140-6736(22)01787-1. Epub 2022 Sep 18.
3
肾去神经术治疗顽固性高血压的疗效:一项系统评价
Cureus. 2024 Aug 16;16(8):e67007. doi: 10.7759/cureus.67007. eCollection 2024 Aug.
4
Exploring Potential Referral Pathways for Renal Artery Denervation and Developing a Centre of Excellence in Ireland.探索肾动脉去神经支配的潜在转诊途径并在爱尔兰建立卓越中心。
SN Compr Clin Med. 2024;6(1):32. doi: 10.1007/s42399-024-01647-9. Epub 2024 Mar 16.
5
Unravelling the effect of renal denervation on glucose homeostasis: more questions than answers?揭开肾去神经支配对葡萄糖稳态影响的神秘面纱:问题多于答案?
Acta Diabetol. 2024 Mar;61(3):267-280. doi: 10.1007/s00592-023-02208-7. Epub 2023 Dec 8.
2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.台湾心脏病学会与台湾高血压学会2022年高血压管理指南
Acta Cardiol Sin. 2022 May;38(3):225-325. doi: 10.6515/ACS.202205_38(3).20220321A.
4
2022 Malaysian Working Group Consensus Statement on Renal Denervation for management of arterial hypertension.2022 年马来西亚工作组共识声明:肾神经去神经术治疗动脉高血压的管理。
Hypertens Res. 2022 Jul;45(7):1111-1122. doi: 10.1038/s41440-022-00937-w. Epub 2022 Jun 1.
5
Patient Selection for Renal Denervation in Hypertensive Patients: What Makes a Good Candidate?高血压患者肾动脉去神经术的患者选择:什么样的患者是合适的?
Vasc Health Risk Manag. 2022 May 13;18:375-386. doi: 10.2147/VHRM.S270182. eCollection 2022.
6
Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial.SPYRAL HTN-OFF MED 试验中 24 小时脉动血流动力学预测臂动脉血压对肾去神经支配的反应。
Hypertension. 2022 Jul;79(7):1506-1514. doi: 10.1161/HYPERTENSIONAHA.121.18641. Epub 2022 May 18.
7
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.在使用抗高血压药物的情况下肾动脉去神经术的长期疗效和安全性(SPYRAL HTN-ON MED):一项随机、假手术对照试验。
Lancet. 2022 Apr 9;399(10333):1401-1410. doi: 10.1016/S0140-6736(22)00455-X. Epub 2022 Apr 4.
8
Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing.高血压患者不遵医嘱:如何制定并实施药物依从性检测。
Hypertension. 2022 Jan;79(1):12-23. doi: 10.1161/HYPERTENSIONAHA.121.17596. Epub 2021 Nov 5.
9
STEP to estimate cardiovascular events by home blood pressure in the era of digital hypertension.在数字高血压时代通过家庭血压评估心血管事件的步骤
Hypertens Res. 2022 Jan;45(1):11-14. doi: 10.1038/s41440-021-00764-5. Epub 2021 Oct 17.
10
Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF.高血压患者的肾去神经支配:由心血管造影和介入学会(SCAI)与美国国家肾脏基金会(NKF)共同主办的专家共识圆桌会议纪要
Catheter Cardiovasc Interv. 2021 Sep;98(3):416-426. doi: 10.1002/ccd.29884. Epub 2021 Aug 3.